Supervisory board

You are here

A prestigious and balanced Supervisory board

Amoéba relies on a prestigious and balanced Supervisory board, composed of financial and industrial experts. 

The speed of Amoéba's development has always been one of its strengths. Our monitoring council is both a reflection of this need to act quickly, and one of the contributors to our rapid advancement.

 

 

Marie-Christine GROS FAVROT

Former Lyon Hospitals intern, holder of a university thesis in biology, Marie-Christine GROS FAVROT is a professor of medicine and an oncologist. In...

Pascal REBER

Pascal REBER

President of the supervisory board of Amoéba

Pascal REBER has filled the position of production director for the Sanofi group for 18 years, and was recently appointed as the General Director to manage the Genzyme factory...

Guy RIGAUD

Guy RIGAUD

Guy RIGAUD, has 25 years experience in seed venture capital, as president of Rhône Alpes creation, then he joined the Amoéba board as the representative of...

Jacques DANCER

Jacques DANCER

After having contributed to creating and developing several companies, mainly in the field of chemistry, Jacques DANCER developed a keen interest in biology. In 2011, he...

Franck LESCURE

Franck LESCURE

Franck LESCURE joined the Auriga Partners team in 2004 in the Life Sciences sector, after several...

Gaëtane SUZENET

Gaëtane SUZENET

Gaëtane Suzenet is Venture Advisor to ASTER CAPITAL, a French investment fund. Previously...

Thomas RIVAL

Thomas RIVAL

Thomas RIVAL is holding a strategic development manager position since 2010 in EVOLEM, an entrepreneur family...